Action Predictive Oncology (POAI)
Société cotée en bourse. Voici le cours, un aperçu de l'activité et l'essentiel à savoir sur Predictive Oncology en septembre 2026.
Predictive Oncology Inc. is engaged in using artificial intelligence (AI) and machine learning to expedite early drug discovery and enable drug development for the benefit of cancer patients worldwide. The Company’s scientifically validated AI platform, PEDAL, is able to predict with 92% accuracy when a tumor sample responds to a certain drug compound, allowing for a more informed selection of drug/tumor type combinations for subsequent in-vitro testing. Through AI, it uses its proprietary biobank of 150,000+ cancer tumor samples, categorized by patient type, against drug compounds to help the drug discovery process and increase the probability of drug development. The Company offers a suite of solutions for oncology drug development from early discovery to clinical trials.
Performance de croissance sur six mois
Aperçu de la performance de l'action
Note des analystes
Analysts suggest keeping Predictive Oncology's stock as it shows limited growth potential.
Santé financière
Predictive Oncology Inc is generating moderate revenue and profit margins, with a positive cash flow.
Voyez plus d'actions en téléchargeant l'application GRATUITEMENT
Cela ne prend que 60 secondes.
Pourquoi investir avec Nemo ?
Zéro commission
Négociez actions, ETF et plus encore sans commission. Gardez une plus grande part de vos gains.
Fiable et réglementé
Membre du groupe Exinity depuis 2015, au service de plus d'un million de clients dans le monde.